These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16091573)

  • 1. Duration of anticoagulation following venous thromboembolism: a meta-analysis.
    Ost D; Tepper J; Mihara H; Lander O; Heinzer R; Fein A
    JAMA; 2005 Aug; 294(6):706-15. PubMed ID: 16091573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
    Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
    Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
    Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
    Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
    Carrier M; Le Gal G; Wells PS; Rodger MA
    Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation Therapy for Venous Thromboembolism in the Real World　- From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of anticoagulant therapy after initial idiopathic venous thromboembolism.
    Frazee LA; Chomo DL
    Ann Pharmacother; 2003 Oct; 37(10):1489-96. PubMed ID: 14519045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is recurrent venous thromboembolism after therapy reduced by low-molecular-weight heparin compared with oral anticoagulants?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandalà M; Papaldo P; Fabi A; Ciccarese M; Cuppone F; Cecere FL; Nuzzo C; Terzoli E; Cognetti F
    Chest; 2006 Dec; 130(6):1808-16. PubMed ID: 17167001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
    Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
    J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis.
    Lopes LC; Eikelboom J; Spencer FA; Akl EA; Kearon C; Neumann I; Schulman S; Bhatnagar N; Guyatt G
    BMJ Open; 2014 Jul; 4(7):e005674. PubMed ID: 24996916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and recurrent venous thromboembolism.
    Prandoni P; Noventa F; Milan M
    Phlebology; 2013 Mar; 28 Suppl 1():99-104. PubMed ID: 23482543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials.
    Limone BL; Hernandez AV; Michalak D; Bookhart BK; Coleman CI
    Thromb Res; 2013 Oct; 132(4):420-6. PubMed ID: 24011386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis.
    Pebanco GD; Kaiser SA; Haines ST
    Ann Pharmacother; 2013 May; 47(5):605-16. PubMed ID: 23606553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature.
    Streiff MB; Segal JB; Tamariz LJ; Jenckes MW; Bolger DT; Eng J; Krishnan JA; Bass EB
    Am J Hematol; 2006 Sep; 81(9):684-91. PubMed ID: 16838335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
    Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
    Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.